Diadia
Our TechnologyResourcesAboutLoginBook a call

© 2026 Diadia. All rights reserved.

About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions
About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions

© 2026 Diadia. All rights reserved.

←Transparency Reports

endocrine · Mechanism Report

Do PDE8B variants raise TSH by altering cAMP signaling?

Common PDE8B genetic variants are associated with modestly higher circulating TSH concentrations due to increased intracellular cAMP breakdown in thyroid cells.

PlausibleJune 19, 202612 Sources

Reasoning Paths

Each route from condition to outcome carries a support score — the product of its edge weights. Select one to isolate it on the figure.

This is what AI claimed

PDE8B genetic variation is associated with higher TSH concentrations via altered cAMP signaling in the thyroid axis.

laying out figure…
2 of 3 paths supported
UnsupportedPlausibleSupported

How to read the figure

Evidence state

  • ●EstablishedStrong, replicated evidence.
  • ◐ModerateEvidence-informed; limited or moderate.
  • ◇PlausibleMechanistically coherent, not established.
  • ✕UnsupportedTested and not supported — link breaks.
  • ?MissingNo evidence either way — untested.

Node shapes

  • BiomarkerA measurable state — a lab value, hormone, or genetic factor.
  • ProcessA biological process, pathway, or mechanism step.
  • ConditionA condition, exposure, intervention, or symptom.
  • OutcomeThe endpoint the claim leads to.

Executive summary

The claim states that common genetic variation in PDE8B correlates with slightly higher baseline TSH, often at the upper-normal or subclinical range. Mechanistically, these variants accelerate cAMP degradation in thyroid follicular cells, blunting the gland’s responsiveness to TSH and provoking a compensatory pituitary-driven rise in circulating TSH to preserve thyroid hormone output.

Verified conclusion

Clinical evidence

  • Robust Genetic Association: Multiple large-scale genome-wide association studies (GWAS) and meta-analyses (such as those involving cohorts of over 10,000 individuals) have consistently identified a strong link between common genetic variations in the phosphodiesterase 8B (PDE8B) gene and elevated serum thyroid-stimulating hormone (TSH) concentrations. Specifically, single nucleotide polymorphisms (SNPs) such as rs4704397, rs2046045, and rs6885099 are highly robust genetic determinants of the hypothalamic-pituitary-thyroid axis set-point.
  • Clinical Presentation: These genetic variants are associated with slightly higher baseline TSH levels, often within the upper limit of the normal reference range or in the subclinical hypothyroid range, without necessarily causing overt thyroid disease or clinical hypothyroidism.

Mechanistic explanations

  • Regulation of intracellular cAMP: The PDE8B gene encodes a high-affinity, cAMP-specific phosphodiesterase that is highly expressed in thyroid follicular cells. It acts as an enzymatic "brake" on intracellular signaling by hydrolyzing cyclic adenosine monophosphate (cAMP), the primary second messenger downstream of the TSH receptor (TSHR).
  • Blunted TSH sensitivity: Genetic variants that alter PDE8B expression or activity lead to accelerated cAMP degradation. This reduction in intracellular cAMP dampens downstream protein kinase A (PKA) activity and impairs the activation of crucial transcription factors like CREB and GLIS3, which are responsible for driving the transcription of thyroid hormone biosynthetic genes (e.g., sodium-iodide symporter, thyroid peroxidase, and thyroglobulin).
  • Compensatory feedback-driven response: Because the thyroid follicular cells are less sensitive to TSH stimulation due to accelerated cAMP breakdown, the thyroid output of thyroxine (T4) and triiodothyronine (T3) slightly decreases. The pituitary gland senses this marginal decline and triggers a compensatory feedback-driven increase in circulating TSH secretion to maintain overall thyroid hormone homeostasis.

Bottom line

Common genetic variations in the PDE8B gene increase circulating TSH concentrations by enhancing intracellular cAMP breakdown in thyroid follicular cells. This blunts the gland's sensitivity to TSH, leading to a compensatory, feedback-driven rise in pituitary TSH secretion to maintain normal thyroid hormone levels.

References

  1. Phosphodiesterase 8B Gene Variants Are Associated with Serum ... — pmc.ncbi.nlm.nih.gov ↗
  2. Phosphodiesterase 8B gene variants are associated with ... - PubMed — pubmed.ncbi.nlm.nih.gov ↗
  3. PDE8B gene Phosphodiesterase 8B - GeneCards — genecards.org ↗
  4. Haplotype analysis of the promoter region of phosphodiesterase ... — pubmed.ncbi.nlm.nih.gov ↗
  5. Phosphodiesterase 8B (PDE8B) gene variants and TSH levels - IRIS — iris.unica.it ↗
  6. Genetic Variants Associated with Serum Thyroid Stimulating Hormone (TSH) Levels in European Americans and African Americans from the eMERGE Network — dx.plos.org ↗
  7. Genetic variants associated with serum thyroid stimulating hormone ... — vumc.org ↗
  8. A meta-analysis of the associations between common variation in ... — academic.oup.com ↗
  9. GLIS3 expression in the thyroid gland in relation to TSH signaling and regulation of gene expression — link.springer.com ↗
  10. Perfluorooctanoic acid disrupts thyroid-specific genes expression and regulation via the TSH-TSHR signaling pathway in thyroid cells. — linkinghub.elsevier.com ↗
  11. Nevirapine Increases Sodium/Iodide Symporter-Mediated Radioiodide Uptake by Activation of TSHR/cAMP/CREB/PAX8 Signaling Pathway in Dedifferentiated Thyroid Cancer — frontiersin.org ↗
  12. GWAS of thyroid stimulating hormone highlights pleiotropic effects and inverse association with thyroid cancer — nature.com ↗

See a full patient report verified like this

Book a walkthrough

Related Claims

Plausible8 sourcesCan obstructive sleep apnea lower testosterone in men?→Plausible5 sourcesDoes a non-elevated LH with low testosterone suggest secondary hypogonadism?→